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ABStrAct
This study investigates substance use disorders among long-distance commercial vehicle 
drivers in Kaduna, Nigeria. Each consecutive 4th long distance driver who was to load 
his vehicle on each day was interviewed using the Schedule for Clinical Assessment in 
Neuropsychiatry (SCAN) to generate an International Classification of Diseases (ICD-10) 
substance use diagnosis until a sample size of 274 was attained. The data was analysed 
using the SPSS version 16.0. The current and life time prevalence of an ICD-10 diagnosis 
was 18.4%, and 21.2% respectively. None of them had received any form of medical 
treatment for drug problems. Substance use disorder occur among long distance 
commercial vehicle drivers, and there is a need to develop a system that identifies 
substance use disorders and provides treatment for drug users as part of a holistic 
approach against drugged-driving.
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introDuction
The use of psychoactive substances is 
common. Globally, it is estimated that in 
2012, 3.5-7% of the world’s population 
aged 15-64 had used an illicit drug mainly 
from the group of cannabis, opioid, co-
caine and amphetamine-type stimulants, 
at least once in the previous year (UNO-
DC, 2014a).  The global prevalence of drug 
use has remained relatively same over the 
past 4 years, but there have been more 
cases of problem drug users and drug 
dependence (UNODC, 2015). There has 
also been an increase in the production 
and consumption of new psychoactive 
substances (NPS), particularly synthetic 
cannabinoids, cathinones and phenethyl-
amines (UNODC, 2015). Worldwide, men 
are thrice more likely than women to use 
illicit substances (UNODC, 2014b).
Substance usehave huge negative 
health (Rehm et al, 2009) and economic 
consequences (Ezzati & Lopez, 2003; 
104
Wuracel et al, 2015).   It can reduce the 
quality of life through disability (Smith, & 
Larson, 2003; De Maeyer et al, 2010) and 
can lead to premature death (UNODC, 
2015).  A study estimated that the disabil-
ity adjusted life years (DALY) for illicit drug 
dependence was responsible for 3.6 mil-
lion years of life lost through premature 
death and 16.4 million years of life lived 
with disability (Degenhardt & Hall, 2012).
Commercial drivers have been docu-
mented to use psychoactive substances 
worldwide (Mathijssen & Houwing, 2005; 
Abiona et al, 2006; Beimess & Davis, 
2006; Labat et al, 2008; Bello et al, 2011; 
Girotto et al, 2014).   Virtually all classes 
of substances have been involved. Long 
distance commercial driving is common-
ly practiced in Nigeria and elsewhere, 
mostly in the developing world where 
other means of transportation such as rail 
system is inadequate to meet demand. 
There are reports of on-the-job consump-
tion of multiple substances  substance 
use by drivers who engage in this pattern 
of driving (Makanjuola, 2007; Lasebikan 
& Baiyewu, 2009; Okpataku, 2015). These 
drivers could develop mental and be-
havioural disorders associated with sub-
stance use and may continue to offend 
or violate traffic regulations on drugs and 
driving as a result of a drug-induced brain 
disease which creates loss of control over 
substance use.
While so much may be known about 
the use of substances by drivers and its as-
sociation with road traffic accidents (Ad-
enekan & Osigbogun, 1999; Lowenstein 
& Koziol-McLain, 2000; Drummer et al, 
2004; Movig et al, 2004; Mir et al, 2012) 
only little or nothing is known about the 
direct effect of these drugs on the mental 
health of these drivers and the behaviour 
that is likely to follow these disorders. 
This study evaluates substance-induced 
disorders in long distance commercial ve-
hicle drivers.
MethoD
The study was conducted in Kaduna, 
Northwest Nigeria. Kaduna is the 3rd most 
populous state in Nigeria, with a popula-
tion of more than 6 million (NPC, 2006). 
It was carried out among all long dis-
tance commercial vehicle drivers who 
consist mostly of young and middle aged 
men of diverse ethno-cultural origin with 
a slight Hausa-Fulani predominance. All 
licensed drivers who have been driving a 
minimum distance of 500km from Kadu-
na for at least 1 year and were registered 
members of the National Union of Road 
Transport Workers (NURTW) Kaduna 
branch, were eligible to participate. The 
NURTW among other roles regulates the 
activities of the motor parks and exercises 
authorities on its members.
It was a cross-sectional descriptive 
study of the drivers. Eligible drivers were 
identified by their vehicle numbers and a 
list of them created. The number of driv-
ers to be selected from each motor park 
was determined by proportional alloca-
tion of a calculated sample size of 270. 
The sample size required was calculated 
using the formula for calculating sample 
size in cross- sectional studies when the 
population is less than 10,000. (Araoye, 
2003). With a prevalence of psychoactive 
substance use in a similar study of about 
43% (Lasebikan & Baiyewu, 2009), and an 
estimate of population of long distance 
drivers in Kaduna city put at about 1000 
by the NURTW, an estimated minimum 
sample of 270 was obtained. However, 
274 drivers were recruited.
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For each of the 10 motor parks, a pro-
portionate sample was taken. Beginning 
with the first driver who was to load his 
vehicle on an interview day at each of 10 
designated motor parks, each consecu-
tive 4th driver was interviewed until the 
sampling fraction for that park was at-
tained. This process was repeated at the 
various motor parks until the sample size 
was attained.
It was a 2-stage assessment. Respon-
dents were initially screened for alcohol 
and other substance use with 2 screen-
ing instruments after which those who 
had problem drug use based on cut-off 
scores were further assessed using a di-
agnostic tool. Drivers responded to the al-
cohol use disorder identification test (AU-
DIT) (Saunders et al, 1993) and the drug 
abuse screening test (DAST-10) (Skinner, 
1982).  Those with a total score of 8 and 
above on the AUDIT and or a total score 
of 3 or greater on the DAST indicating the 
likelihood of harmful use or dependence 
(Skinner, 1982; Yudko, 2007), were further 
evaluated for alcohol and other substance 
use disorders using the Schedule for 
Clinical Assessment in Neuropsychiatry 
(SCAN). The SCAN is a set of instruments 
aimed at assessing, measuring and clas-
sifying the psychopathology and behav-
ior associated with the major psychiatric 
disorders of adult life (WHO, 1999).  A 
computer program of the instrument was 
used in this study to generate diagnoses 
of the mental and behavioural disorders 
due to psychoactive substance use. The 
author administered the SCAN, having 
been trained in a World Health Organiza-
tion Reference Centre on the use of the 
SCAN. Drivers were also asked to indicate 
if they had ever received medical treat-
ment for drug-related health problems. 
The instruments were translated to Hausa 
language and the interview conducted in 
Hausa, as this was the major language of 
communication by the study population.
Ethical clearance was sought and ap-
proved for the study by the Health Eth-
ics Research Committee of the Ahmadu 
Bello University Teaching Hospital Zaria 
and the Kaduna state Ministry of Health. 
In addition, written informed consents 
were sought from the respondents and 
they were assured of confidentiality for 
participation in the study and that there 
was not going to be any consequence for 
non-participation.
The data obtained was analysed by 
means of descriptive statistics using the 
Statistical Package for Social Sciences 
(SPSS version 16.0) (SPSS 16.0).
reSultS
Seventy nine subjects met the mini-
mum cut-off score for the screening in-
struments requiring the application of the 
SCAN. Thirty subjects out of those who 
screened negative were administered the 
SCAN. None of them had an ICD-10 diag-
nosis. On the application of the SCAN, the 
current and life time prevalence of an ICD-
10 diagnosis was 18.4%, and 21.2% re-
spectively. The diagnosis found was harm-
ful use and dependence (see Table 1).
No respondent had received any form 
of medical assistance with drug-related 
health problems.
DiScuSSion
The drivers in this study were found to 
be using various psychoactive substances. 
Some of the reasons for this is that drivers 
may wish to alter some basic physiologic 
process in order to meet other competing 
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demand such as the need to take stimu-
lants to stay awake to drive for longer pe-
riod (Okpataku, 2015). Substances such as 
amphetamine and cocaine were not re-
corded as drugs currently used. Drug use 
is influenced by factors such as availabil-
ity, affordability, accessibility and accept-
ability. Cocaine is an illicit drug in Nigeria 
and an important substance being hunt-
ed down by the drug law enforcement 
agents in the country. A World Health 
Organization global survey on psychoac-
tive substances recorded low proportion 
of cocaine users in Africa, including Nige-
ria (Degenhardt et al., 2008). This could 
explain the near absence of these drugs 
among the respondents. Although it by 
no means eliminates the possibility of on-
going use nor does this undermine their 
wish to use these substances as this study 
was based on self-report of drug use 
with its limitations. Lowenstein et al in a 
study to determine crash responsibility 
in injured motorist found more subjects 
with serum levels of cannabis and alcohol 
than other drugs (Lowenstein & Koziol-
McLain, 2000).  Similarly, in the work done 
in France to determine the prevalence of 
psychoactive substance use in truck driv-
ers, the investigators found more urine 
samples with cannabinoids than other 
drugs (Labat et al, 2008)
About one of every five driver in this 
study was found to have a current ICD-
10 substance use diagnosis. Lasebikan et 
al in their study found the prevalence of 
an ICD-10 diagnosis using the Composite 
International Diagnostic Interview (CIDI) 
to be 29.4% (Lasebikan & Baiyewu, 
2009). This may partly be attributable 
to the different sociocultural settings 
in which these studies were conducted 
and the data collecting instruments. As 
both studies depended on self-reporting 
for screening substance users from non-
users, underreporting could also be a 
factor.
There is relative dearth of studies of 
substance use disorders among vehicle 
drivers. Reports on substance use by 
drivers have largely been centred on the 
description and of the presence or oth-
erwise of the various drugs. This is prob-
ably so because concerns about the use 
of psychoactive substances by drivers has 
essentially being related to traffic safe-
OKPATAKU
table 1. Psychoactive substance use disorders
Drug type harmful use Dependence
PY lB no uSe PY lB no uSe
Alcohol 5 1.8% 6 2.2% 263 96.0% 1 0.4% 3 1.1% 269 98.2%
Cannabis 4 1.5% 4 1.5% 266 97.1% 1 0.4% 1 0.4% 272 99.3%
Opioids 3 1.1% 0 0% 271 98.9% 2 0.7% 0 0% 272 99.3%
Nicotine 8 2.9% 9 3.3% 257 93.8% 27 9.9% 5 1.8% 242 88.3%
Anxiolytics 0 0% 0 0% 274 100% 0 0% 0 0% 247 100%
Kolanuts 3 1.1% 1 0.4% 270 98.5% 0 0% 0 0% 274 100%
Solvent 0 0% 0 0% 274 100% 0 0% 0 0% 274 100%
Cocaine 0 0% 0 0% 274 100% 0 0% 0 0% 274 100%
Amphetamine 0 0% 0 0% 274 100% 0 0% 0 0% 274 100%
Caf.subs. 2 0.7% 0 0% 272 99.3% 0 0% 0 0% 274 100%
PY=past year, LB= lifetime before, Caf subs= Caffeinated substances
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ty and the risk for injury it portends for 
passengers and other road users when 
drivers use substances and drive. The fo-
cus has not really been extended to the 
safety and personal health risks of these 
drugs on the user-the drivers in this case. 
Transportation by road arguably still 
remains the most important means of 
movement for humans and goods in de-
veloping countries. Commercial vehicle 
drivers travel over hundreds of miles 
daily. This is a tedious job for drivers 
who are fatigue-prone and sleep on the 
wheels. Psychoactive substance use has 
been reported to be responsible for traf-
fic injuries and death globally (Movig et 
al, 2008; Gjerde et al, 2011; Bogstrand et 
al, 2012). The direct impact of the drugs 
on the health of the driver may not have 
taken into consideration in these analy-
ses. There perhaps could be an underesti-
mation of the burden of substance use by 
vehicle drivers.
In most jurisdictions, law enforcement 
agents and road traffic authorities en-
force the law against drugged-driving and 
apply punitive measures on drivers who 
violate laws as it relates to the use of sub-
stances. Divers who abuse substances are 
not spared the mental and behavioural 
disorders arising from substance use. 
Drug-dependent drivers may be unable to 
adhere to traffic regulations on control or 
prohibition of substance use during driv-
ing as a result of a drug-induced brain 
disease. They should benefit from treat-
ment just like other non- driver patients 
who are perceived as sick too. They would 
need medical assistance than mostly pu-
nitive measures. For a drug-dependent 
driver, medical referral and management 
may be an effective strategy to stay ab-
stinent while driving than punishment. 
Several of the drivers had been arrested 
for drugged-driving. However, from this 
study, none of the respondents had ever 
benefited from medical help for a drug 
use disorder even though they were in a 
major metropolis.
That some drivers had met the diagno-
sis of drug use disorders means a focused 
and purposeful intervention including 
drug treatment may be needed to assist 
drivers especially those dependent on 
drugs as part of a holistic approach to 
curtail the problems associated with the 
use of psychoactive substances among 
drivers. 
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